.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Colorcon
US Army
Queensland Health
Cerilliant
AstraZeneca
US Department of Justice
Dow
Healthtrust
Novartis

Generated: September 20, 2017

DrugPatentWatch Database Preview

Drug Master Files for: erythromycin

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
633III8/5/1963ELANCO DIV ELI LILLY AND COINVEST DRUG STREPTOMYCIN,TYLOSIN, ERYTHROMYCIN & PENICILLIN BOLUS(VET)
709III10/24/1963ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVGALLIMYCIN (R)-10(ERYTHROMYCIN THIOCYANATE, ABBOTT)
730III11/7/1963ELANCO PRODS DIV ELI LILLY AND COSTREPTOMYCIN-TYLOSIN-ERYTHROMYCIN-PENICILLIN COMBIN. ALONE & W/DES(VET
734III11/15/1963ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVGALLIMYCIN-10(ERYTHROMYCIN,ABBOTT) & PRO-GEN (ARSANILIC ACID) (VET)
747III11/12/1963DOW CHEMICAL COZOAMIX AND ERYTHROMYCIN THIOCYANATE (VET)
821III6/19/1964ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVANTIBIOTIC M-188 (MACROLIDE ANTIBIOTIC OF THE ERYTHROMYCIN GROUP)
1458III12/15/1969ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVERYTHROMYCIN B
2904III4/13/1977ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVERYTHROMYCIN PHOSPHATE
5858III6/3/1985FOREST LABORATORIES INCERYTHROMYCIN 500MG. C.R.TABLETS
6957III4/30/1987SOUTH FLORIDA BIOAVAILABILITY CLINIC INCDETERMINATION OF ERYTHROMYCIN IN HUMAN SERUM BY BIOLUMINOMETRY ASSAY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Deloitte
QuintilesIMS
Moodys
Express Scripts
US Department of Justice
Teva
Accenture
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot